BLOOD CANCER
Clinical trials for BLOOD CANCER explained in plain language.
Never miss a new study
Get alerted when new BLOOD CANCER trials appear
Sign up with your email to follow new studies for BLOOD CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetic test aims to Fine-Tune drug dosing for vulnerable cancer patients
Disease control Recruiting nowThis study is testing a personalized approach to dosing an antifungal drug called voriconazole for patients with blood cancer. It compares using a patient's genetic test results to guide dosing against the current standard method. The goal is to see if the personalized method hel…
Matched conditions: BLOOD CANCER
Phase: PHASE2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for transplant patients battling stubborn blood cell problems
Disease control Recruiting nowThis study is testing whether the drug isatuximab can help adults who develop severe, treatment-resistant low blood counts after a stem cell transplant for blood cancer. The goal is to see if the drug can effectively restore healthy blood cell levels in these patients. It is for …
Matched conditions: BLOOD CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists train Patients' own cells to hunt blood cancer
Disease control Recruiting nowThis early-stage study is testing a new, personalized treatment for several types of blood cancer that are hard to treat. Doctors take a patient's own immune cells (T cells), genetically modify them in a lab to recognize and attack their specific cancer, and then infuse them back…
Matched conditions: BLOOD CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New Triple-Threat attack on hidden leukemia cells aims to stop relapse
Disease control Recruiting nowThis study is testing whether a new combination of three drugs can safely control hidden leukemia cells and prevent the cancer from coming back in adults with acute myeloid leukemia (AML). The goal is to see if adding a new drug called tagraxofusp to two standard drugs helps elim…
Matched conditions: BLOOD CANCER
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Moving to rest: daily exercise tested to ease sleep troubles for kids fighting cancer
Symptom relief Recruiting nowThis study is testing whether doing a special, adapted physical activity every day can improve sleep for children and teenagers (ages 5-16) who are being treated for blood cancer. Researchers will compare the effects of daily activity to doing it just once over a four-day period.…
Matched conditions: BLOOD CANCER
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Mar 09, 2026 14:25 UTC
-
Searching for clues to predict deadly transplant complication
Knowledge-focused Recruiting nowThis study aims to find biological markers that can predict how severe a gut complication will be after a blood cancer transplant. Researchers will collect data from 90 patients to build a tool that helps doctors personalize treatment. The goal is to improve outcomes by identifyi…
Matched conditions: BLOOD CANCER
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC
-
Blood test could predict which cancer patients benefit from immunotherapy
Knowledge-focused Recruiting nowThis study aims to identify blood markers that can predict whether cancer patients will respond to FDA-approved immunotherapy treatments. Researchers will follow 1,500 patients receiving treatments like pembrolizumab or nivolumab, tracking their response over six months. The goal…
Matched conditions: BLOOD CANCER
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:27 UTC